These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2587023)

  • 1. A comparative study concerning the treatment of active toxoplasmic retinochoroiditis with argon laser and medication (follow-up 2-9 years).
    Theodossiadis GP; Koutsandrea C; Tzonou A
    Ophthalmologica; 1989; 199(2-3):77-83. PubMed ID: 2587023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
    Aleixo AL; Curi AL; Benchimol EI; Amendoeira MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004685. PubMed ID: 27136081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Argon laser coagulation in the treatment of active chorioretinitis (author's transl)].
    Theodossiadis G
    Klin Monbl Augenheilkd; 1981 Jun; 178(6):446-8. PubMed ID: 7196472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute choroidal ischemia associated with toxoplasmic retinochoroiditis.
    Khairallah M; Yahia SB; Zaouali S; Jenzeri S; Attia S; Messaoud R
    Retina; 2007 Sep; 27(7):947-51. PubMed ID: 17891022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest in treatment with subconjunctival clindamycin in toxoplasmic retinochoroiditis].
    Ben Zina Z; Abid D; Kharrat W; Chaker N; Aloulou K; Chaâbouni M
    Tunis Med; 2001 Mar; 79(3):157-60. PubMed ID: 11471444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
    Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
    Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasmic retinochoroiditis: resolution without treatment of the perilesional satellite dark dots seen by indocyanine green angiography.
    Guex-Crosier Y; Auer C; Bernasconi O; Herbort CP
    Graefes Arch Clin Exp Ophthalmol; 1998 Jun; 236(6):476-8. PubMed ID: 9646094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.
    Silveira C; Belfort R; Muccioli C; Holland GN; Victora CG; Horta BL; Yu F; Nussenblatt RB
    Am J Ophthalmol; 2002 Jul; 134(1):41-6. PubMed ID: 12095806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent secondary frosted branch angiitis after toxoplasmosis vasculitis.
    Oh J; Huh K; Kim SW
    Acta Ophthalmol Scand; 2005 Feb; 83(1):115-7. PubMed ID: 15715571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
    Timsit JC; Bloch-Michel E
    J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photocoagulation of active toxoplasmic retinochoroiditis.
    Ghartey KN; Brockhurst RJ
    Am J Ophthalmol; 1980 Jun; 89(6):858-64. PubMed ID: 6966892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal vascular involvement in acute toxoplasmic retinochoroiditis.
    Theodossiadis P; Kokolakis S; Ladas I; Kollia AC; Chatzoulis D; Theodossiadis G
    Int Ophthalmol; 1995; 19(1):19-24. PubMed ID: 8537191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series.
    Kianersi F; Naderi Beni A; Naderi Beni Z; Ghanbari H
    Semin Ophthalmol; 2015 May; 30(3):181-7. PubMed ID: 24175641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in a giant macular hole formed secondary to toxoplasmic retinochoroiditis.
    Tanaka R; Obata R; Sawamura H; Ohtomo K; Kaburaki T
    Can J Ophthalmol; 2014 Oct; 49(5):e115-8. PubMed ID: 25284113
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-γ +874 T/A as risk factors for recurrence in a survival analysis.
    Aleixo ALQDC; Vasconcelos C de Oliveira R; Cavalcanti Albuquerque M; Biancardi AL; Land Curi AL; Israel Benchimol E; Reis Amendoeira MR
    PLoS One; 2019; 14(2):e0211627. PubMed ID: 30753197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired toxoplasmic chorioretinitis].
    Marduel R; Larmande J; Rossazza C
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):719-23. PubMed ID: 2686848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis.
    Mauget-Faÿsse M; Mimoun G; Ruiz-Moreno JM; Quaranta-El Maftouhi M; De Laey JJ; Postelmans L; Soubrane G; Defauchy M; Leys A
    Retina; 2006 Apr; 26(4):396-403. PubMed ID: 16603957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.
    Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vascular occlusions complicating acute toxoplasmic retinochoroiditis.
    Gentile RC; Berinstein DM; Oppenheim R; Walsh JB
    Can J Ophthalmol; 1997 Aug; 32(5):354-8. PubMed ID: 9276124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.